WELLPRIMER / PEPTIDE READER

Peptide medicines & injections

Connect medicines, conditions and health goals. Understand what each connection means—and what the evidence supports.

Explore metabolism and weight, bone health, hormone disorders, and the evidence behind recovery and ageing claims.

8English & Chinese topic guides17referenced connections

Start with the scope

Authorization and labelled-use references mainly describe the United States. Changing country does not verify local approval, supply or delivery. Investigational compounds, compounded products and approved medicines are distinguished. No clinician review is claimed.

Showing 2 guides; references are linked for each connection.

U.S. labelled-use references2026-10-17

Octreotide: hormone excess and selected tumour-related symptoms

Octreotide is a peptide analogue of somatostatin. It can suppress several hormone signals; that pharmacology is relevant to defined disorders, not proof of general hormone balancing.

Route / discussion scope: Injectable formulations; route varies with the exact product
Conditions / goals discussed: Acromegaly · Neuroendocrine tumours

OctreotideAcromegaly / excess growth hormone
Suppresses growth-hormone release in selected patients.
Requires specialist diagnosis and follow-up. Source ↗
OctreotideSelected secretory tumour symptoms
Can control carcinoid-related flushing/diarrhoea and VIPoma-related diarrhoea.
Symptom control is not equivalent to cure. Source ↗

Health goals & wellness limits

The useful health-management link is follow-up of the diagnosed endocrine or tumour condition. Claims of detoxification or broad anti-ageing benefit cannot be inferred from hormone suppression.

Read the full guide & references →

U.S. labelled-use references2026-10-17

Desmopressin: water balance, selected bleeding disorders and sodium safety

Desmopressin is a synthetic peptide analogue of vasopressin. It influences water handling and can affect clotting-factor release. Different routes and preparations serve different clinical purposes.

Route / discussion scope: Intravenous or subcutaneous for specified injection products/uses
Conditions / goals discussed: Central diabetes insipidus · Selected bleeding disorders

Desmopressin injectionCentral diabetes insipidus
Provides antidiuretic activity in a defined deficiency disorder.
Do not confuse with glucose-lowering treatment. Source ↗
Desmopressin injectionSelected haemophilia A / type I VWD
Can increase relevant clotting-factor availability.
Not suitable for all bleeding disorders or VWD types. Source ↗

Health goals & wellness limits

Preserving hydration and treating a water-balance disorder are different tasks. This medicine is not an everyday hydration or rejuvenation injection.

Read the full guide & references →

Make a wellness claim testable

Which condition or measurable outcome is the goal?
Does the evidence come from human trials, laboratory work or marketing?
Do the ingredient, formulation, route and population match the product?
How are local authorization, prescribing, quality and follow-up verified?

Explore all disease–medicine connections →